Solvenz Fund Performance

Solvenz Fund Proforma does not guarantee future results. Performance data is proforma, and current returns may be higher or lower. Share price and return will vary, and you may have a gain or loss when you sell your shares. To obtain a prospectus free of charge, contact Carlisle Management Company Here.

Yearly Performance Review

 

Solvenz Growth Fund Proforma


Scenario Explanation

Base Case Scenario

- Policies are purchased at a 14.5% IRR

- The expected mortality is experienced as planned.

Scenario 1 (10% extension) – Experienced mortality curve has a median of 10% longer than original expectation

- Policies are purchased at a 14.5% IRR

- The expected mortality is not experienced as planned.  The resulting experience is a curve with a median 10% longer than the original expectation.

-  Based on our current portfolio in the Solvenz fund: a 10% increase in experienced mortality curve would result in a reduction in achieved IRR of 4.4%.

Scenario 2 (20% extension) - Experienced mortality curve has a median of 20% longer than original expectation

- Policies are purchased at a 14.5% IRR

- The expected mortality is not experienced as planned.  The resulting experience is a curve with a median 20% longer than the original expectation.

- Based on our current portfolio in the Opportunistic fund: a 20% increase in experienced mortality curve would result in a reduction in achieved IRR of 8.3%.

Scenario 3 (market shift 1%) – Experienced mortality is as expected – Market rates move from 14.5% to 13.5% on the 13th month, and from 13.5% to 12.5% on the 25th month.

- Based on a portfolio of policies with an LE of 120 months, a change in IRR from 14.5% to 13.5% results in 8.4% increase in the value of the policies. 

- From 13% to 12% the change in value is an increase of 9.5%.

- The expected mortality is experienced as planned.

Scenario 4 (2% reduction) – Experienced mortality is 2% earlier than expected.

- Policies are purchased at a 14.5% IRR

- The expected mortality is not experienced as planned.  The resulting experience is a curve with a median 2% shorter than the original expectation.

- Based on our current portfolio in the Solvenz fund: a 2% decrease in experienced mortality curve would result in an increase of achieved IRR of 1.0%.

Scenario 5 (7% reduction) – Experienced mortality is 7% earlier than expected.

Policies are purchased at a 14.5% IRR

- The expected mortality is not experienced as planned.  The resulting experience is a curve with a median 7% shorter than the original expectation.

- Based on our current portfolio in the Solvenz fund: a 7% decrease in experienced mortality curve would result in an increase of achieved IRR of 3.7%.

Request a Private Consult

Join Our Newsletter